logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Wilma Barcellini

fondazione irccs cà granda ospedale maggiore policlinico
H指数:58
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study

eltrombopag添加到标准免疫抑制治疗中作为一线疗法治疗重症再生障碍性贫血：EBMT-SAAWP RACE研究3期随机优越性研究的长期结果

American Journal of Hematology
IF9.9
2026-07-280
OAAI
Antonio M. Risitano; Simona Iacobelli; Austin Kulasekararaj; Marleen van Os; Sofie R. Terwel; Joe Tuffnell; Brian Piepenbroek; Morag Griffin; Constantijn J. M. Halkes; Christian Recher; Fiorenza Barraco; Edouard Forcade; Juan Carlos Vallejo; Beatrice Drexler; Jean-Baptiste Mear; Roochi Trikha; Shreyans Gandhi; Anna Maria Raiola; L. G. M. Daenen; Marco R. de Groot; Etienne Daguindau; Erfan Nur; Wilma Barcellini; Nigel H. Russell; Louis Terriou; Anna Paola Iori; Walter Barberi; Anna Sureda; Isabel Sánchez-Ortega; Blanca Xicoy; Isidro Jarque; James Cavenagh; Flore Sicre de Fontbrune; Camilla Frieri; Talha Munir; Jennifer M. L. Tjon; Suzanne Tavitian; Aline Praire; Laurence Clement; Florence Rabian; Luana Marano; Anita Hill; Elena Palmisani; Petra Muus; Serena Marotta; Fabiana Cacace; Marica Laurino; Jakob R. Passweg; Gérard Socié; Ghulam J. Mufti; Carlo Dufour; Régis Peffault de Latour; Severe Aplastic Anaemia Working Party of the EBMT
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study

意大利阵发性睡眠性血红蛋白尿症患者中拉伏利珠单抗的临床实际应用：来自REACTION观察性研究的证据

Annals of Hematology
IF2.4
2026-01-220
OAAI
Anna Paola Iori; Antonio De Vivo; Eros Di Bona; Giovanni Caocci; Francesca Fioritoni; Fabio Ciceri; Eloise Beggiato; Davide Rapezzi; Angela Amendola; Amalia Figuera; Carmine Selleri; Francesco Longu; Bruno Fattizzo; Alessandra Tucci; Alessandro Cignetti; Valeria Amico; Simona Sica; Elisabetta Metafuni; Simona Raso; Tiziana Anna Urbano; Luana Marano; Nicola Di Renzo; Pierangelo Spedini; Alessandro Rambaldi; Francesco Lanza; Cristina Clissa; Cristina Danesin; Maria Bruna Greve; Sergio Cabibbo; Alessandra Ori; Francesca Cassanelli; Federica Sottana; Benedetta Campolo; Giulia Gasparri; Fabio Carini; Wilma Barcellini
Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

Iptacopan治疗免疫性血小板减少症和冷凝集素病：一项全球性二期篮式临床研究

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2025-12-010
OAAI
Roth, Alexander; Barcellini, Wilma; Ademokun, Christine; Jang, Junho; Lozano, Maria Luisa; Ferreiras, David Valcarcel; Pascual-izquierdo, Cristina; Chitnis, Shripad; Matviykiv, Sofiya; Vitaliti, Alessandra; Chen, Chi; Katsanou, Vasiliki; Chawla, Raghav; Al-samkari, Hanny
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience

阵发性夜间血红蛋白尿症患者突破性溶血的特征：一项国际多中心经验

American Journal of Hematology
IF9.9
2025-08-110
OAAI
Bruno Fattizzo; Giacinto Luca Pedone; Elisabetta Metafuni; Eloise Beggiato; Valentina Giai; Esther Natalie Oliva; Antony Ricchiuti; Marta Bortolotti; Simona Raso; Daniela Carlino; Mara Memoli; Sofia Vecchi; Jennifer Vidler; Sukanya Gogoi; Shreya Goel; Anna Corby; Roochi Trikha; Sneha Balakrishnan; Francesco Passamonti; Anna Paola Iori; Simona Sica; Shreyans Gandhi; Wilma Barcellini; Austin Kulasekararaj
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors

口服iptacopan单药治疗阵发性夜间血红蛋白尿症：来自在抗C5治疗患者中进行的开放标签、随机、III期APPLY-PNH试验和既往未经补体抑制剂治疗的患者的开放标签、单臂、III期APPOINT-PNH试验的最终48周结果

lancet haematology
IF0
2025-05-280
PRE
Antonio M Risitano; Austin G Kulasekararaj; Phillip Scheinberg; Alexander Röth; Bing Han; Jaroslaw P Maciejewski; Yasutaka Ueda; Carlos M de Castro; Eros Di Bona; Rong Fu; Li Zhang; Morag Griffin; Saskia M C Langemeijer; Jens Panse; Hubert Schrezenmeier; Wilma Barcellini; Vitor A Q Mauad; Philippe Schafhausen; Suzanne Tavitian; Eloise Beggiato; Régis Peffault de Latour
Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial

达尼可潘作为拉武利珠单抗或依库珠单抗的附加疗法在阵发性夜间血红蛋白尿症患者中的长期患者报告结局：来自3期ALPHA试验的数据

BLOOD
IF23.1
2024-11-050
PRE
Piatek, Caroline; Lee, Jong Wook; Griffin, Morag; Nishimura, Jun-Ichi; Patriquin, Christopher; Schrezenmeier, Hubert; Barcellini, Wilma; Shammo, Jamile; Gaya, Anna; Mahdi, Mohammed; Liu, Peng; Myren, Karl-Johan; Messali, Andrew; de Fontbrune, Flore Sicre; Panse, Jens; Kulasekararaj, Austin G.

研究方向

暂未获取到该数据
B
Bruno Fattizzo
H 指数:34论文数:293被引数:5,126
A
Anna Zaninoni
H 指数:26论文数:111被引数:2,205
J
Juri Alessandro Giannotta
H 指数:20论文数:83被引数:1,334
P
Paola Bianchi
H 指数:43论文数:361被引数:6,442
E
Elisa Fermo
H 指数:31论文数:170被引数:3,560
A
Alberto Zanella
H 指数:61论文数:505被引数:2.3万
A
Austin Kulasekararaj
H 指数:55论文数:461被引数:1.1万
A
Agostino Cortelezzi
H 指数:53论文数:484被引数:1.0万
D
Dario Consonni
H 指数:81论文数:796被引数:2.4万
A
Alexander Röth
H 指数:47论文数:245被引数:1.0万